Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

Howard James F., Utsugisawa Kimiaki, Benatar Michael, Murai Hiroyuki, Barohn Richard J., Illa Isabel, Jacob Saiju, Vissing John, Burns Ted M., Kissel John T., Muppidi Srikanth, Nowak Richard J., O'Brien Fanny, Wang Jing-Jing, Mantegazza Renato, Vécsei László (kollab. közrem.): Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
LANCET NEUROLOGY, (16) 12. pp. 976-986. ISSN 1474-4422 (2017)

[img] Text
2017._Howard_J._Safety_and_efficacy_of_eulizumab__Lancet_Neur._u.pdf - Published Version
Korlátozott. Repository staff only

Download (568kB) | Request a copy
Item Type: Article
Journal or Publication Title: LANCET NEUROLOGY
Date: 2017
Volume: 16
Number: 12
Page Range: pp. 976-986
ISSN: 1474-4422
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3298840
DOI id: https://doi.org/10.1016/S1474-4422(17)30369-1
Date Deposited: 2018. Jan. 16. 12:48
Last Modified: 2018. Jan. 16. 12:48
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12702

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year